Moreover, the authors observed that DEHP treatment induced increased expression of two inflammatory mediators, namely, CCR2 and MCP-1, in the neutrophils of ASD, but not in TD children’s neutrophils; this effect can be prevented by the pre-treatment of the neutrophils with antioxidant compounds. The gene discussed is CCL2; the disease is thanatophoric dysplasia.